ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 95 filers reported holding ATHIRA PHARMA INC in Q3 2021. The put-call ratio across all filers is 1.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $68 | -31.3% | 33,600 | 0.0% | 0.01% | -25.0% |
| Q2 2023 | $99 | +17.9% | 33,600 | 0.0% | 0.01% | +14.3% |
| Q1 2023 | $84 | -15.2% | 33,600 | +8.0% | 0.01% | -22.2% |
| Q4 2022 | $99 | -100.0% | 31,100 | +62.8% | 0.01% | -55.0% |
| Q1 2022 | $258,000 | +3.6% | 19,100 | 0.0% | 0.02% | +5.3% |
| Q4 2021 | $249,000 | +21.5% | 19,100 | -12.6% | 0.02% | +11.8% |
| Q3 2021 | $205,000 | -8.5% | 21,850 | 0.0% | 0.02% | -5.6% |
| Q2 2021 | $224,000 | – | 21,850 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 1,630,744 | $21,249,000 | 2.19% |
| VR Adviser, LLC | 1,000,000 | $13,030,000 | 1.78% |
| ACUTA CAPITAL PARTNERS, LLC | 310,030 | $4,040,000 | 1.70% |
| Ikarian Capital, LLC | 860,000 | $11,207,000 | 1.67% |
| Bristlecone Advisors, LLC | 761,563 | $9,923,000 | 1.19% |
| Perceptive Advisors | 6,851,832 | $89,280,000 | 0.69% |
| DAFNA Capital Management LLC | 160,983 | $2,098,000 | 0.53% |
| PATHSTONE FAMILY OFFICE, LLC | 1,442,247 | $18,792,000 | 0.47% |
| Potomac Capital Management, Inc. | 40,000 | $521,000 | 0.46% |
| RTW INVESTMENTS, LP | 1,906,557 | $24,842,000 | 0.36% |